Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Bogdan Muresan"'
Autor:
Abderrahmane Bouredji, Bogdan Muresan, Xuan-Trinh Truong, Laurence Lumière, Jérémie Pourchez, Valérie Forest
Publikováno v:
Environment International, Vol 190, Iss , Pp 108885- (2024)
There is currently limited data on the potential effects of tire and road wear particles (TRWP) on human health. TRWP include tire fragments, but also road wear materials, dust, adsorbed gaseous pollutants and different types of inclusions that could
Externí odkaz:
https://doaj.org/article/01445a72402e4680825e447787d1a357
Autor:
Bayarmagnai Weinstein, Bogdan Muresan, Sara Solano, Antonio Vaz de Macedo, YoonJung Lee, Yu-Chen Su, Yeseul Ahn, Gabriela Henriquez, Christina Carmago, Gwang-Jin Kim, David O. Carpenter
Publikováno v:
INNOVATIONS in Pharmacy, Vol 12, Iss 4 (2021)
Despite favorable results of CAR T-cell therapy for relapsed/refractory large B-cell lymphoma (R/R LBCL), several challenges remain, including incomplete response, immune-mediated toxicity, and antigen-loss relapse. We delineated the relative clinica
Externí odkaz:
https://doaj.org/article/845e08d651ef47c5be4a6d7ead52914f
Autor:
T Alexander Russell-Smith, Laura Gurskyte, Bogdan Muresan, Carla M Mamolo, Ana Gezin, Joseph C Cappelleri, Bart Heeg
Publikováno v:
Future Oncology. 18:2029-2039
Some patients with acute myeloid leukemia (AML) have no response to initial treatment or have a response that is subsequently lost. Follow-on treatment options after that initial stage are limited, especially for patients who are not able to have int
Autor:
Tjalf Ziemssen, Anna Kurzeja, Bogdan Muresan, Jennifer S Haas, Jessica Alexander, Maurice T Driessen
Publikováno v:
Neurodegenerative Disease Management. 12:93-107
Aim: To evaluate adherence, healthcare resource utilization (HRU) and costs for glatiramer acetate (GA; injectable), dimethyl fumarate (oral) and teriflunomide (oral) in relapsing multiple sclerosis. Patients & methods: Retrospective analyses of a cl
Autor:
Mark Oppe, Bogdan Muresan, Katie Chan, Xenia Radu, Bob G. Schultz, Robin S. Turpin, Arnaud Nucit, Elisabetta Fenu
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research.
Inflammatory bowel disease poses significant social and economic burdens. We assessed the budget impact of including the recently approved subcutaneous (SC) formulation of vedolizumab as maintenance therapy (MT) in patients with ulcerative colitis (U
Autor:
Cristina Pires Camargo, Sara Solano, Bogdan Muresan, Gwang-Jin Kim, Yu-Chen Su, YoonJung Lee, Yeseul Ahn, Gabriela M. Henriquez Luthje, Bayarmagnai Maggie Munkhjargal, David O. Carpenter, Antonio Vaz de Macedo
Publikováno v:
Principles and Practice of Clinical Research Journal. 7:34-39
Background: Relapsed and refractory large B cell lymphomas (RR-LBCL) have a poor prognosis. Chimeric antigen receptor (CAR) T-cell therapies have shown considerably high response rates even in RR-LBCL patients who fail to achieve remission after mult
Autor:
Isabela Roxana Birs, Clara Mihaela Ionescu, Robin De Keyser, Cosmin Copot, Cristina Ioana Muresan, Bogdan Muresan, Constantin Florin Caruntu
Publikováno v:
2022 13th Asian Control Conference (ASCC).
Autor:
Henry Chrystyn, Nawar Bakerly, Mark Levy, Guilherme Safioti, Sanjay Gandhi, John Logan, Bogdan Muresan
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB12
Autor:
Alexandru-Ion Marinescu, Horea-Bogdan Muresan, Alina-Delia Calin, Adriana-Mihaela Coroiu, Maria Talla
Publikováno v:
2021 IEEE International Conference on Big Data (Big Data).